Spatial Biomarker Panels for Clinical Trials Read more 

Why early developability assessment is a strategic necessity in modern antibody discovery Read more 

Italy's Alfasigma pens $690M deal for GSK itching drug awaiting FDA approval decision Read more 

Max Eldridge

Max has more than ten years in Life Sciences recruitment, He collaborates with executives to foster growth in Pharma, Biotech, CRO, TechBio, and Medical Device sectors​

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top